SPIRA-P and SPIRA-T Devices Enter Full National Launch Mode Reports Camber Spine

Camber Spine, a leading innovator in spine and medical technologies has announced that it is entering into the next phase of the complete national launch of the SPIRA-P Posterior Lumbar Spacer and has recently commercialized its Spira-T Oblique Posterior Lumbar Spacer.

Part of Camber’s SPIRA product platform, the SPIRA-P Posterior Lumbar Spacer is versatile to accommodate open and minimally invasive PLIF or TLIF procedures and features a patented open architecture design for optimal endplate load distribution. Additionally, its uniquely designed surface allows for cell adhesion and bone cell proliferation while its interconnected porosity design mimics bone.

The SPIRA-T Oblique Posterior Lumbar Spacer is designed specifically to accommodate traditional and “insert and rotate” TLIF procedures.  SPIRA-T is designed  to efficiently accommodate an oblique approach  and to optimize segmental lordosis.

As with all products within Camber’s SPIRA technology platform, SPIRA-P and SPIRA-T include strategically placed and optimal sized openings for graft packing. The SPIRA products are designed to decrease the risk of subsidence with optimized endplate distribution and provide good visibility for fusion.

SPIRA-P and SPIRA-T will be among the systems displayed at Camber’s booth (#302) this week at the International Society for the Advancement of Spine Surgery (ISASS) Annual Meeting at the Atlantis Hotel in the Bahamas. Camber’s booth will also be hosting a series of focus sessions:

 

  • “The Solution to the Posterior Approach”
  • “The Anterior Column Solution”
  • “The Advanced Biologics Solution”

SPIRA implants are 3D printed. This specialized manufacturing technology allows Camber to create unique patented structures featuring open arched matrices and proprietary surfaces designed to enhance fusion and promote bone growth.

“We are excited to continue to make our SPIRA-P technology available to more surgeons around the country,” said Camber Co-Founder and CEO, Daniel Pontecorvo, “Providing structural stability following discectomy, our SPIRA Posterior Lumbar Spacers have different shapes and designs to accommodate a broader array of posterior and transforaminal approaches and techniques.”

With further expansions to its lines of award-winning SPIRA and ENZA technology platforms due later this year, along with training labs and educational programs to support ALIF, LLIF, OLIF, PLIF and TLIF spine surgery techniques, the company is focused on fulfilling its mission to support the full array of surgical approaches.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version